ProShares UltraShort NASDAQ Biotechnology
7 hedge funds and large institutions have $2.94M invested in ProShares UltraShort NASDAQ Biotechnology in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$1.49M |
2 |
2
IMC Chicago
Chicago,
Illinois
|
$590K |
3 |
3
Morgan Stanley
New York
|
$3K |
Top Sellers
1 |
OMC
1
Old Mission Capital
Chicago,
Illinois
|
$0 |
2 |
2
Citadel Advisors
Miami,
Florida
|
$652K |
3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$205K |